European Commission approves Celltrion's Remsima IV liquid formulation

Biotheryx completes enrolment in ongoing Phase 1a trial of BTX-9341 for HR+/HER2- breast cancer

Henlius and Organon secure first US approval for pertuzumab biosimilar POHERDY

CHMP issues positive opinion for DAWNZERA in hereditary angioedema

Longeveron secures US patent for stem cell therapy targeting aging-related frailty

ABIONYX Pharma advances strategic alliance talks with IHU SEPSIS to build global sepsis innovation platform

Mabwell receives NMPA approval to begin Phase II trial for IL-11-targeting drug for pathological scarring

Vascarta and CUNY report positive preclinical results in glioblastoma treatment

Akeso reveals preclinical research data for novel antagonistic monoclonal antibody aimed at IL-1RAP (AK135)

Sanofi and Regeneron's Dupixent meets all endpoints in pivotal AFRS study; sBLA accepted for FDA priority review

Eilean Therapeutics presents TE205 in vivo data at 4th International Conference on Microbiology and Immunology

Arctic Bioscience reports significant anti-inflammatory effects from psoriasis drug candidate HRO350 in phase 2b trial

Zoetis announces EU approval for Portela to relieve osteoarthritis pain in cats

Johnson & Johnson reports durable two-year remission data for TREMFYA in Crohn's disease

Trellus Health signs contract with leading global CRO and expands clinical trial offerings